Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% cream
1305020D0AAAJAJ
|
Calcipotriol | Calcipotriol | Skin | 1,374 |
|
Clairette 2000/35 tablets
1306020C0BFAAAA
|
Clairette | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | 1,373 |
|
Veil finishing powder
130802000BBBJA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 1,334 |
|
Wynzora 50micrograms/g / 0.5mg/g cream
1305020D0BHAAAJ
|
Wynzora | Calcipotriol | Skin | 1,315 |
|
Fluocinolone acetonide 0.025% cream
1304000N0AAABAB
|
Fluocinolone acetonide | Fluocinolone acetonide | Skin | 1,292 |
|
Zinc oxide impregnated medicated stockings
1313010S0AAAAAA
|
Zinc oxide | Medicated stockings | Skin | 1,274 |
|
Terbinafine 1% spray
131002030AAABAB
|
Terbinafine hydrochloride (Topical) | Terbinafine hydrochloride | Skin | 1,233 |
|
Betamethasone valerate 0.1% / Neomycin 0.5% cream
1304000F0AACBCB
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 1,227 |
|
Bazuka Extra Strength 26% gel
1307000M0BXABBM
|
Bazuka | Salicylic acid | Skin | 1,199 |
|
Hydrocortisone 2.5% ointment
1304000V0AABDBD
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 1,197 |
|
Anabact 0.75% gel
1310012K0BEAAAR
|
Anabact | Metronidazole | Skin | 1,189 |
|
Lipobase cream
130201000BBAIA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 1,172 |
|
Clobetasol 500microg/Neomycin 5mg/Nystatin 100,000u/g oint
1304000G0AACBCB
|
Clobetasol propionate | Clobetasol propionate | Skin | 1,153 |
|
Dandrazol 2% shampoo
1309000I0BEAAAA
|
Dandrazol | Ketoconazole | Skin | 1,151 |
|
Eucerin DermoCapillaire Calming urea shampoo
1302010U0BGAGAS
|
Eucerin | Urea | Skin | 1,148 |
|
Nizoral 2% cream
1310020L0BBAAAA
|
Nizoral (Skin) | Ketoconazole | Skin | 1,138 |
|
Urea 10% lotion
1302010U0AAAMAM
|
Urea (Emollient) | Urea | Skin | 1,129 |
|
Crystacide 1% cream
1310050H0BBABAA
|
Crystacide | Hydrogen peroxide | Skin | 1,122 |
|
Derbac-M 0.5% liquid
1310040M0BBAAAD
|
Derbac-M | Malathion | Skin | 1,102 |
|
Gamolenic acid 40mg capsules
1305010I0AAAAAA
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | 1,078 |
|
Diprosone 0.05% cream
1304000D0BBAAAA
|
Diprosone | Betamethasone esters | Skin | 1,075 |
|
Hydrocortisone acetate 1% cream
1304000X0AAAAAA
|
Hydrocortisone acetate (Topical) | Hydrocortisone acetate | Skin | 1,042 |
|
Silver nitrate 40% caustic pencils
1307000Q0AAABAB
|
Silver nitrate | Silver nitrate | Skin | 1,032 |
|
Hydrocortisone 0.25% / Crotamiton 10% cream
1304000V0AAAJAJ
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 1,012 |
|
Dimeticone 4% lotion
1310040V0AAAAAA
|
Dimeticone (Parasiticidal) | Dimeticone (Parasiticidal) | Skin | 999 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.